$MLSS News

Milestone Scientific Directors Convert $465K Loans Into Equity, Eliminating Debt And Achieving Debt‑Free Balance Sheet

Milestone Scientific Inc. (MLSS) Q2 2026 Earnings Call Transcript

Conference Call: Milestone Scientific Affirms FY2026 Sales Guidance of $9.800M-$10.200M vs $9.910M Est

Conference Call: Milestone Scientific Sees Q3 Sales $2.300M-$2.500M vs $2.510M Est

Transcript: Milestone Scientific Q2 2026 Earnings Conference Call

Milestone Scientific Q2 EPS $(0.01), Inline, Sales $2.841M Beat $2.700M Estimate

Milestone Scientific Announces Strategic Federal Distribution Partnership with Red One Medical to Expand Commercial Access for the CompuFlo® Epidural System

Milestone Scientific Launches First Phase of AI Strategy with Pilot Debut of Milo, an AI-enabled Digital Engagement Platform, at ASPN 2026

Milestone Scientific Reports Preliminary 1H 2026 Revenue of ~$5.0M, +9% YoY; Q2 2026 Revenue of ~$2.8M, +21% YoY

Milestone Scientific Expects Q2 Revenue Of ~$2.8M, Up 21% YoY; H1 Revenue Of ~$5M, Up 9% YoY

Milestone Scientific Strengthens Board to Support Next Phase of Growth

Milestone Scientific Highlights Growing Clinical Adoption and Expanding Physician Acceptance of CompuFlo® Across Epidural, Neuromodulation, and Interventional Pain Procedures

Milestone Scientific Notes Growing Clinical Adoption And Physician Acceptance Of Its CompuFlo Epidural System After Research Publication

Milestone Scientific Inc (MLSS) Q1 2026 Earnings Call Highlights: Strategic Growth Amid Global ...

Milestone Scientific Inc. (MLSS) Q1 2026 Earnings Call Transcript

Milestone Scientific Reports Financial Results for First Quarter 2026

Full Transcript: Milestone Scientific Q1 2026 Earnings Call

Reported earlier, Milestone Scientific Affirms FY2026 Sales Guidance of $9.800M-$10.200M vs $9.910M Est

Milestone Scientific Q1 EPS $(0.01), Inline, Sales $2.162M Miss $2.252M Estimate

Milestone Scientific Schedules First Quarter 2026 Financial Results and Business Update Conference Call